DPPIV Inhibitor, P32/98 for cell activation

Cell-permeable. A potent, specific, and competitive transition-state substrate analog inhibitor of dipeptidyl peptidase IV (DPPIV) (Ki =130 nM). May be used in cell cuture (1-10 μM) or Experimental anti-diabetic agent. Has been used in vivo and cell culture.

N/A

136259-20-6

260.36

Biochemicals

(2S, 3S)-2-Amino-3 –methyl-1-(thiazolidin-3-yl)pentan-1-one hemi-fumarate

C₉H₁₈N₂OS · 1/2(C₄H₄O₄)

White solid

N/A

No

No

≥98% by TLC

-20°C

Gel pack

24 months

Protect from air and moisture

cell

For cells, cell lines and tissues in culture till half confluency.Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.